PrECOG
@PrECOGonc
Innovative cancer research studies developed through industry partnerships and networks. Supporting @eaonc's efforts to advance cancer care
You might like
Kudos to @VirtuaHealth for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
How well does osimertinib—with or without chemotherapy—work to control EGFR-positive #LungCancer in patients not participating in a clinical trial? The PrE1702 #RealWorldData research study aims to find out. More: bit.ly/pre1702-study #LCSM #RWD #RWE
After being diagnosed with #PancreaticCancer, Steven Merlin found hope through a #clinicaltrial. Now as an @eaonc advocate, he shares his perspective on the benefits of clinical trials. Read his inspiring story: bit.ly/beatingtheodds… cc: @letswinpc, @PanCAN, @SeenaMagowitz
Great work to @prohealthcare for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. More: bit.ly/4hyZUue #LCSM
blog-ecog-acrin.org
Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
DYK only 17% of US cancer trials are federally funded—yet they’re far more likely to study rare cancers, pediatric cancers, & multimodality treatments? Public funding = innovation where it’s needed most. More: bit.ly/47kYNME #Oncology #CancerResearch @DrJoeUnger @SWOG
The PrE1702 #RealWorldData research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive #LungCancer in patients not participating in a clinical trial. Learn more: bit.ly/pre1702-study #LCSM #RWD #RWE
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium!🩻🩺📈#EAOnc
.@TJUHospital is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
The PrE1702 #RealWorldData research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive #LungCancer in patients not participating in a clinical trial. Learn more: bit.ly/pre1702-study #LCSM #RWD #RWE
Great to see Prof. @perth_meso_dr present results of our international phase 3 #mesothelioma trial #DREAM3R today at #ESMO25 a really enjoyable academic trial collaboration between @TOGAANZ @PrECOGonc
The PrE1702 #RealWorldData research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive #LungCancer in patients not participating in a clinical trial. Learn more: bit.ly/pre1702-study #LCSM #RWD #RWE
.@mfldclinic is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/4hyZUue
blog-ecog-acrin.org
Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
How well does osimertinib—with or without chemotherapy—work to control EGFR-positive #LungCancer in patients not participating in a clinical trial? The PrE1702 #RealWorldData research study aims to find out. More: bit.ly/pre1702-study #LCSM #RWD #RWE
The PrE1702 #RealWorldData research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive #LungCancer in patients not participating in a clinical trial. Learn more: bit.ly/pre1702-study #LCSM #RWD #RWE
Kudos to the following institutions for enrolling their first patients in #RealWorldData #PatientRegistry PrE1702: Sibley Memorial Hospital, Good Samaritan University Hospital, and @NorthwesternU! More info here: bit.ly/pre1702-study #LCSM #RWD #RWE
How well does osimertinib—with or without chemotherapy—work to control EGFR-positive #LungCancer in patients not participating in a clinical trial? The PrE1702 #RealWorldData research study aims to find out. More: bit.ly/pre1702-study #LCSM #RWD #RWE cc: @PremierHealthOH
Kudos to @ValleyHealthNJ for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/4hyZUue
blog-ecog-acrin.org
Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
The PrE1702 #RealWorldData research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive #LungCancer in patients not participating in a clinical trial. Learn more: bit.ly/pre1702-study #LCSM #RWD #RWE cc: @JPS_Health
Kudos to Aurora Saint Luke’s Medical Center for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/4hyZUue
blog-ecog-acrin.org
Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
How well does osimertinib—with or without chemotherapy—work to control EGFR-positive #LungCancer in patients not participating in a clinical trial? The PrE1702 #RealWorldData research study aims to find out. More: bit.ly/pre1702-study #LCSM #RWD #RWE cc: @PremierHealthOH
United States Trends
- 1. #DWTS 14.2K posts
- 2. Robert 93.9K posts
- 3. Elaine 68.9K posts
- 4. Carrie Ann N/A
- 5. Veterans Day 461K posts
- 6. Jeezy 3,048 posts
- 7. #WWENXT 5,437 posts
- 8. Northern Lights 4,734 posts
- 9. Louisville 9,016 posts
- 10. #aurora 1,641 posts
- 11. Woody 21.7K posts
- 12. Jaland Lowe N/A
- 13. Meredith 2,825 posts
- 14. Bindi 1,306 posts
- 15. Tom Bergeron N/A
- 16. Britani N/A
- 17. Oweh N/A
- 18. #DancingWithTheStars N/A
- 19. Tangle and Whisper 6,190 posts
- 20. Vogt 2,340 posts
You might like
-
Joseph A. Sparano, MD
@jsparano -
ECOG-ACRIN Cancer Research Group
@eaonc -
Joshua Reuss
@Joshua_Reuss -
Heather McArthur, MD, MPH, FASCO
@hmcarthur -
Patrick Boland
@PMBolandMD -
Kristen Ciombor
@KristenCiombor -
Melina Marmarelis
@MMarmarelis -
Komal Jhaveri, MD, FACP, FASCO
@jhaveri_komal -
Isabel Preeshagul
@ipreeshagul -
Mridula George
@MridulaGeorgeMD -
Rafeh Naqash, MD, FASCO
@thenasheffect -
Vered Stearns
@VeredStearns -
Alex Spira, M.D.
@AlexSpiraMDPhD -
Young Kwang Chae, MD, MPH, MBA
@youngkwangchae -
Janice Mehnert, MD
@JaniceM10
Something went wrong.
Something went wrong.